Keratinocyte growth factor is a potent and speci®c mitogen for dierent types of epithelial cells, including keratinocytes of the skin. Furthermore, it has been implicated in morphogenetic processes of several organs. To further de®ne the mechanisms of KGF action in the skin, we attempted to identify genes which are regulated by KGF in keratinocytes. Using the dierential display RT ± PCR technology, a gene was identi®ed which was strongly induced in these cells by treatment with KGF but not with serum growth factors or pro-in¯ammatory cytokines. Molecular cloning of the full-length cDNA revealed a strong homology of the corresponding gene product with a bovine non-selenium glutathione peroxidase. Upon transfection of COS cells with the fulllength cDNA, a 27 kD cytoplasmic protein was obtained which had the expected size of glutathione peroxidase. Expression of the novel gene was detected in normal human skin and at particularly high levels in psoriatic skin, indicating a possible in vivo function of the protein in this tissue. Identi®cation of a peroxidase as a KGFregulated gene suggests that prevention from oxygen toxicity is a novel and speci®c mechanism of KGF action.
Introduction
Keratinocyte growth factor (KGF) is a member of the ®broblast growth factor (FGF) family of mitogens which also includes acidic FGF (aFGF, FGF-1), basic FGF (bFGF, FGF-2), FGF-3, FGF-4, FGF-5, FGF-6, (Basilico and Moscatelli, 1992) , FGF-8 (Tanaka et al., 1992) , FGF-9 (Miyamoto et al., 1993) and FGF-10 (Yamasaki et al., 1996) . These factors stimulate proliferation and/or dierentiation of a wide variety of cell types in vitro and in vivo (Basilico and Moscatelli, 1992) . KGF diers from the other members of the FGF family by its high speci®city for epithelial cells, including keratinocytes of the skin Finch et al., 1989) . The latter express the only known high-anity receptor for KGF which is a splice variant of FGF receptor 2, a transmembrane protein tyrosine kinase (Miki et al., 1992) .
KGF is expressed at low levels in non-wounded skin but is strongly up-regulated in dermal ®broblasts upon skin injury in mice and humans (Werner et al., 1992; Marchese et al., 1995) . This induction is dramatically reduced during wound healing in healing-impaired animals (Werner et al., 1994a; Brauchle et al., 1995) , suggesting that overexpression of KGF after injury is important for normal repair. This hypothesis was supported by in vivo studies which demonstrated severe defects in skin morphogenesis and wound repair upon targeted expression of a dominantnegative KGF receptor in the epidermis of transgenic mice (Werner et al., 1994b) . The abnormalities seen in these animals included defects in the epithelium such as epidermal atrophy and reduced wound re-epithelialization but also abnormalities in the underlying connective tissue, suggesting direct and indirect eects of KGF on dierent parts of the skin.
The molecular mechanisms which underlie the action of KGF in the skin have not yet been elucidated and the genes which are regulated by this growth factor are largely unknown. For this purpose we have used the dierential display RT ± PCR (DDRT ± PCR) technology to identify and clone genes which are regulated by this growth factor in human keratinocytes. The product of one of the identi®ed genes was highly homologous to a bovine non-selenium glutathione peroxidase. Expression of this gene is positively regulated in keratinocytes by KGF but not by serum growth factors. Since glutathione peroxidases are very important for the detoxi®cation of reactive oxygen species (ROS) our studies suggest that up-regulation of this enzyme provides a novel mechanism of KGF action by reducing oxidative stress in these cells.
Results

Identi®cation of a KGF-inducible gene in HaCaT keratinocytes
To identify novel KGF-regulated genes in keratinocytes we used the HaCaT cell line which is known to express functional KGF receptors (Frank et al., 1995) . Quiescent cells were treated for 3, 6, 9 or 24 h with puri®ed KGF. RNAs from three independent experiments were analysed by DDRT ± PCR for dierentially expressed genes in KGF-treated and non-treated cells. One of the PCR products was found at particularly high levels after ampli®cation of cDNA from KGFtreated cells. By contrast, this fragment was hardly detectable when cDNA from quiescent cells or FCStreated cells was used (data not shown). The fragment was therefore isolated from the gel, reampli®ed and cloned. Dierential expression of the corresponding gene was con®rmed by RNase protection assay and Northern blot analysis. Expression of this gene was hardly detectable in quiescent keratinocytes but was strongly induced by KGF treatment of the cells. Maximal expression levels were seen within 6 ± 9 h after addition of KGF. Twenty-four hours after KGF stimulation, expression of this gene had signi®cantly declined (Figure 1a, upper panel) . By contrast, expression of another novel gene which was also identi®ed by DDRT ± PCR was even reduced under the same conditions ( Figure 1a , lower panel). Due to its regulation by KGF, the novel gene was designated KRG-1 (KGF-regulated gene 1). Northern blot analysis demonstrated the presence of a single 1.9 kb mRNA (data not shown). Upregulation of this transcript was dependent on protein de novo synthesis, since pre-treatment of keratinocytes with 10 mg/ml cycloheximide completely inhibited the eect of KGF (data not shown).
Regulation of the novel gene by growth factors and cytokines
To determine whether induction of KRG-1 is speci®c for KGF, we analysed the eect of serum, puri®ed serum growth factors and cytokines (Figure 1b) . Surprisingly, no induction was observed for with FCS which contains a mixture of dierent growth factors. Furthermore, EGF, another potent keratinocyte mitogen, had no signi®cant eect on KRG-1 expression. Thus induction of KRG-1 expression is not a general response of keratinocytes to growth factor treatment. In contrast to keratinocyte mitogens, inhibitors of keratinocyte proliferation such as TGF-b1 or TNF-a completely suppressed KRG-1 expression. These results were reproduced with a second set of RNAs from an independent tissue culture experiment. Taken together, these ®ndings suggest that induction of KRG-1 is a novel and speci®c eect of KGF.
The novel KGF-regulated gene is a member of a multigene family
To determine if KRG-1 is a unique gene or a member of a multigene family, human chromosomal DNA was analysed by Southern blot analysis. Using low stringency washing conditions, several additional bands could be detected which were not seen after a high stringency wash (Figure 2 
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Figure 2 KRG-1 is a member of a multigene family. Human chromosomal DNA was digested with HindIII (H), EcoRI (E) or BamHI (B) restriction endonucleases, respectively, and analysed by Southern blot analysis. Hybridization was performed at low and high stringency to demonstrate the presence or absence of homologous genes frame of the KRG-1 cDNA (data not shown). This ®nding suggests the existence of several related genes in the human genome.
The novel KGF-regulated gene encodes a protein which is highly homologous to a non-selenium glutathione peroxidase
To obtain the full-length cDNA of KRG-1, we constructed a cDNA library from RNA of KGFstimulated HaCaT cells. Using the DDRT ± PCR fragment from the 3'-end of the mRNA as a probe, 10 positive phage clones were isolated from this library. Two of them had the expected 1.7 kb insert, suggesting that the full-length cDNA had been cloned. Upon sequencing of one of these inserts, a single 672 nt open reading frame and a long 3'-non-translated sequence was detected (Figure 3a) . The 3'-end of this cDNA was identical to the fragment obtained by DDRT ± PCR. Using a probe derived from 3'-end of the open reading frame as a template for RNase protection assay, we con®rmed the induction of this gene by KGF (data not shown), demonstrating that the cloned cDNA does indeed correspond to the KRG-1 mRNA. Sequence comparison of the nucleotide sequence with known sequences from the EMBL database demonstrated that the cDNA was almost identical to a previously identi®ed but unpublished human cDNA (AC D14662; human messenger RNA for ORF) of as yet unknown function. Furthermore, the putative protein encoded by our cDNA revealed a high homology to several open reading frames from other organisms (plants and yeast) which had not been characterized so far (Figure 3b ). The most striking ®nding was a 85% homology to a protein which had recently been isolated from bovine ciliary body and from which only the sequence of a 25 amino acid aminoterminal peptide had been obtained (Shichi and Demar, 1990) (Figure  3c ). Interestingly, this protein represents a functional glutathione peroxidase which catalyzes reduction of hydrogen peroxide and organic hydroperoxides by glutathione but does not contain selenium and lacks glutathione S-transferase activity (Shichi and Demar, 1990) . The striking homology of the putative KRG-1 protein and this peroxidase suggested that we had cloned the human homologue.
Despite the presumable functional similarities, a computer alignment of the sequences of our protein, (Shichi and Demar, 1990) . The sequence of the human protein is shown on the top. The sequence of the bovine protein is shown below the human selenium glutathione peroxidase (Mullenbach et al., 1987; Sukenaga et al., 1987) , the human phospholipid hydroperoxide glutathione peroxidase (Esworthy et al., 1994) and the human class pi glutathione S-transferase (Kano et al., 1987) which also exhibits peroxidase activity (Wendel, 1981) did not reveal obvious similarities. However, after a more detailed comparison of these sequences we identi®ed several sequence motifs in our protein which revealed similarities to at least one of the other enzymes (Table  1) . Therefore it seems likely that the KRG-1 product has certain structural similarities both to Se-containing glutathione peroxidases and to glutathione S-transferase isozymes.
The novel KGF-regulated gene gives rise to a 27 kD cytoplasmic protein
To characterize the protein encoded by the KRG-1 cDNA, it was transiently expressed in COS cells as a fusion protein with a 16 amino acid IVH epitope tag at the carboxyterminus. A protein of approximately 27 kD was detected in the lysate of the cells transfected with this construct (Figure 4a , lane 3) but not in vector-transfected cells (lane 1) or cells transfected with a cDNA encoding a dierent protein (lane 2). By contrast, this protein could not be detected in the conditioned medium (data not shown). The size of this protein corresponds to the size of the non-selenium glutathione peroxidase from bovine ciliary body, providing further evidence for the identity of both proteins. This result was reproduced with a novel antiserum directed against a carboxyterminal peptide of the protein. This antiserum also detected a 27 kD protein in the lysate of KGF-stimulated keratinocytes (data not shown). By immuno¯uorescence staining, a uniformly cytoplasmic localization was determined (Figure 4b ).
The novel KGF-regulated gene is expressed in vivo in normal and diseased skin Glutathione peroxidases are important scavengers of ROS which are continuously produced in the epidermis, particularly upon exposure to u.v. light or to several xenobiotics. Most importantly, high levels of ROS are generated by leukocytes and macrophages in in¯amed tissues via the respiratory burst (Schopf et al., 1992) . Therefore we determined the in vivo expression of KRG-1 in normal skin and in aected areas of patients suering from the in¯ammatory skin disorder psoriasis. KRG-1 was expressed at low levels in control skin but at signi®cantly higher levels in aected skin of all tested psoriatic patients (eight patients) ( Figure 5 ). This ®nding demonstrates that KRG-1 expression does not only occur in vitro in cultured keratinocytes but also in vivo in human skin. Furthermore, the strong overexpression of the gene in psoriatic skin suggests a role of the KRG-1 encoded peroxidase in the defense against ROS generated in in¯ammatory skin disease.
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Discussion
KGF is a potent and highly speci®c mitogen for epithelial cells Finch et al., 1989) . Furthermore, KGF and its receptor have been shown to play a crucial role in epithelial morphogenesis of several organs such as the skin (Werner et al., 1994b) , the lung (Peters et al., 1994) , the prostate , and the seminal vesicles (Alarid et al., 1994) . Thus investigating the mechanisms of action of KGF should provide new insights into the role of growth factors in proliferative and morphogenetic processes. Using the DDRT ± PCR technology we have identi®ed several genes which are upregulated in these cells upon KGF treatment. One of these genes (KRG-1) seemed to be of particular interest, since its expression was only induced by KGF but not by serum growth factors. Sequence analysis of the full-length cDNA revealed the presence of a single open reading frame encoding a 224 amino acid protein which revealed striking similarity to a bovine non-selenium glutathione peroxidase (Shichi and Demar, 1990 ). This enzyme is distinct from the selenoenzymes and from the pi-class glutathione S-transferase which also exhibits peroxidase activity (Mullenbach et al., 1987; Sukenaga et al., 1987; Esworthy et al., 1994; Kano et al., 1987; Wendel, 1981; Flohe, 1982) . The striking sequence homology of the non-selenium glutathione peroxidase and the product of KRG-1, the identical size of both proteins, and the sequence similarities of the KRG-1 product with other glutathione peroxidases or with glutathione S-transferase highly suggest that we had cloned the human homologue of this gene. A similar gene seems to be present in various other species, including bacteria and plants. Furthermore, we have cloned and sequenced the aminoterminus of the mouse homologue and thereby detected a 93% homology between the aminotermini of the bovine and murine proteins. This ®nding demonstrates a high conservation of this protein, suggesting that it could be functionally important.
ROS such as oxyradicals and peroxides are important mediators of tissue injury in a variety of physiological and pathological conditions, such as wound healing and acute and chronic in¯ammatory diseases (Halliwell and Gutteridge, 1984; Ames and Shigenaga, 1993) . Under these conditions, activated phagocytes produce ROS during the`respiratory burst' (Schopf et al., 1992) . Thus detoxi®cation of these molecules is essential for the cells in in¯amed tissues, since prolonged exposure to ROS might lead to severe tissue injury and even neoplastic transformation. Cells can be protected from oxidative damage by the presence of several enzymes such as catalase, peroxidases and superoxide dismutases (Michiels et al., 1994) . Interestingly, manganese superoxide dismutase (LoÈ ntz et al., 1995) , the pi-class glutathione Stransferase (Aceto et al., 1992) , and ± as shown in this study ± also non-selenium glutathione peroxidase are overexpressed in psoriatic skin which is characterized by hyperproliferation and aberrant dierentiation of the keratinocytes and the presence of in¯ammatory in®ltrates in the dermis and epidermis (Christophers and Krueger, 1987) . Thus overexpression of these enzymes might have a protective role in the defense against ROS produced by the highly abundant in¯ammatory cells.
The induction of a glutathione peroxidase by KGF therefore suggests a novel function of this growth factor in the defense against ROS. This could be of particular importance in the skin which is exposed to many ROS-generating agents such as various xenobiotics and also u.v. irradiation which can induce skin cancer upon chronic exposure (Pentland, 1994) . Furthermore, it might protect keratinocytes from peroxides generated during the`respiratory burst' that occurs during the early phase of wound repair (Clark, 1991) . Consistent with this hypothesis, expression of KGF is strikingly induced during wound healing in mice and humans (Werner et al., 1992; Marchese et al., 1995) and preliminary data from our laboratory also demonstrate overexpression of the KGF-induced peroxidase in the hyperproliferative epithelium at the wound edge but not in other areas of the wound tissue. Since keratinocytes are the only cells in the wound that express functional KGF receptors, speci®c induction of KRG-1 expression of KGF might also occur in vivo.
Surprisingly, mice lacking the KGF gene revealed only a hair defect, whereas the development of all organs and even the wound healing process appeared grossly normal (Guo et al., 1996) . This is in contrast to previous results obtained with dominant-negative KGF receptors, where severe abnormalities were detected upon blocking of KGF receptor signalling in the lung Probe control skin #1 control skin #2 Patient #1 Patient #2
Figure 5 KRG-1 is strongly overexpressed in psoriatic skin. 10 mg total cellular RNA from normal skin and from biopsies of patients suering from psoriasis were analysed by RNase protection assay for the presence of KRG-1 mRNA. The results for two biopsies from psoriatic skin and two biopsies from control skin are shown. 1000 c.p.m. of the hybridization probe were loaded in the lane labeled`probe' and used as a size marker or in the skin, respectively. Expression of the dominant-negative receptor in the developing lung epithelium inhibited lung branching morphogenesis (Peters et al., 1994) , and targeted expression of the mutant receptor in the skin caused abnormalities in skin development and severe wound healing defects (Werner et al., 1994b) . Since the dominant-negative KGF receptor mutant also binds other types of FGF and thereby inhibits their biological eects, the normal phenotype of KGF knockout mice suggests that other KGF receptor ligands, such as aFGF, bFGF, FGF-3 (Miki et al., 1992; Mathieu et al., 1996) or possibly new members of the FGF family which are homologous to KGF (Yamasaki et al., 1996) might compensate for the lack of KGF in these animals. In summary, our data suggest a novel role of KGF and possibly other KGF receptor ligands in the defense against oxidative stress in addition to the known functions of KGF in epithelial cell migration and proliferation. This hypothesis is supported by a recent study, demonstrating decreased hyperoxia-induced mortality in rats after intratracheal instillation of KGF (Panos et al., 1995) . Furthermore, preliminary data from the same laboratory suggest that KGF can reduce oxidant-induced DNA death in alveolar type II cells in vitro (Panos et al., 1995) . This resistance to oxidative damage is not due to overexpression of catalase or superoxide dismutase. It might be possible that induction of KRG-1 in pneumocytes could be responsible for this eect. Since KGF is the only tested factor that can induce expression of this gene, defense against ROS could be a novel and speci®c eect of this multipotent growth factor.
Materials and methods
Growth factor treatment of keratinocytes
HaCaT keratinocytes (Boukamp et al., 1988) were grown to con¯uence in DMEM containing Pen/Strep and 10% fetal calf serum (FCS). They were rendered quiescent by serum starvation for 16 h and subsequently treated with 10 ng/ml recombinant human KGF, 10% FCS, 20 ng/ml epidermal growth factor (EGF), 5 ng/ml transforming growth factor b1 (TGF-b1), 100 U/ml interleukin-1b (IL1b), or 300 U/ml tumor necrosis factor a (TNF-a), respectively. Cells were harvested at dierent time points after addition of these factors and used for RNA isolation.
DDRT ± PCR
DDRT ± PCR was performed essentially as described (Bauer et al., 1994) . Brie¯y, 2 mg total cellular RNA was reverse transcribed using 5'-(T) 12 CG-3'(A) as a primer. PCR was performed in a total reaction volume of 20 ml using 10 mCi [ 35 S]dATP, 25 mM of primer A, 5 mM of primer B (5'-(T) 4 GGCTCC-3') and 1 U Taq polymerase (Perkin Elmer). 40 cycles were performed (30 s 948C, 60 s 428C, 30 s 728C).
RNA isolation and RNase protection assays
Isolation of total cellular RNA and RNase protection assays were performed as described (Chomczynski and Sacchi, 1987; Werner et al., 1992) . Probe DNAs: (i) 245 bp cDNA fragment corresponding the 3'-end of the KRG-1 cDNA. This fragment had been obtained by DDRT ± PCR (ii); 318 bp probe corresponding to the 3'-end of the KRG-1 open reading frame.
Tissue specimens
Control skin specimens were taken from healthy adult volunteers and biopsy specimens from lesional psoriatic skin were taken from patients with untreated, longstanding psoriasis.
Southern blot analysis
Chromosomal DNA from human ®broblasts was digested with HindIII, EcoRI or BamHI restriction endonucleases, respectively, fractionated by agarose gel electrophoresis and transferred to nitrocellulose ®lters. Filters were hybridized with 32 P-labeled cDNA probes corresponding to the non-coding 3'-end or to the open reading frame of the KRG-1 cDNA, respectively.
Cloning of a full-length KRG-1 cDNA A cDNA library was generated from 6 mg polyadenylated RNA of KGF-stimulated HaCaT cells using the Uni-Zap XR cDNA cloning kit (Stratagene) and the Gigapack Gold III packaging extract (Stratagene) as described by the manufacturers. Filters were hybridized and washed at high stringency using standard methods (Maniatis et al., 1982) . A 32 P-labeled cDNA fragment from the 3'-end of the KRG-1 mRNA was used as a probe.
Expression of KRG-1 in COS cells, Western blotting and immuno¯uorescence
The complete coding region of the KRG-1 cDNA was fused in frame to the coding sequence of 16 amino acids of the in¯uenza virus hemagglutinin (IVH) at the 3'-end. The hybrid cDNA was inserted into the pCG expression vector, in which expression of KRG-1 was driven by the CMV promoter. COS cells were transiently transfected with this construct by the DEAE-dextran method. Brie¯y, cells were incubated for 3 h with DMEM, 2.5% FCS, 0.4 mg DEAE dextran per ml, 0.1 mM chloroquine phosphate and 1 mg of expression plasmid per ml. The transfection medium was then replaced by DMEM containing 10% FCS. 72 h after transfection cells were analysed for KRG-1 expression.
For Western blot analysis, cells were lysed in 1% Triton X-100, 20 mM Tris/HCl pH 8.0, 137 mM NaCl, 10% glycerol, 2 mM EDTA, 1 mM PMSF, 0.15 U/ml aprotinin. 60 mg protein were analysed by western blotting using a monoclonal antibody directed against the IVH epitope or a polyclonal antiserum directed against a carboxyterminal peptide of the KRG-1 protein, respectively. An alkaline phosphatase detection system (Promega) was used. For immuno¯uorescence, cells were ®xed for 3 min in ice-cold methanol/acetone 1:1. KRG-1 protein was detected with the IVH-antibody and an FITC-conjugated antibody directed against mouse IgG (Boehringer Mannheim Biochemicals).
